Huaren Pharmaceutical Co., Ltd. (SHE:300110)
China flag China · Delayed Price · Currency is CNY
3.150
0.00 (0.00%)
Apr 30, 2026, 3:04 PM CST

Huaren Pharmaceutical Ratios and Metrics

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Apr '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
3,7243,7244,1614,9895,0135,675
Market Cap Growth
-1.87%-10.51%-16.59%-0.47%-11.67%1.48%
Enterprise Value
4,9024,4255,7056,1926,6797,116
Last Close Price
3.153.153.524.194.194.72
PE Ratio
---26.5327.7343.52
Forward PE
-41.1841.1841.1841.1841.18
PS Ratio
2.802.823.083.053.103.64
PB Ratio
4.024.103.031.801.932.32
P/TBV Ratio
10.1310.7715.623.213.654.82
P/FCF Ratio
13.3110.9113.9819.2128.54-
P/OCF Ratio
12.109.5412.9116.3323.00-
EV/Sales Ratio
3.693.354.223.784.124.56
EV/EBITDA Ratio
18.1816.0423.1713.1516.9919.71
EV/EBIT Ratio
30.4626.3543.8717.9527.3131.40
EV/FCF Ratio
17.5212.9719.1723.8438.03-
Debt / Equity Ratio
1.401.360.930.560.640.75
Debt / EBITDA Ratio
4.794.435.183.324.245.09
Debt / FCF Ratio
4.623.624.296.029.52-
Net Debt / Equity Ratio
1.201.210.810.480.560.58
Net Debt / EBITDA Ratio
4.143.974.522.833.693.94
Net Debt / FCF Ratio
3.953.213.745.138.25-2.35
Asset Turnover
0.430.430.320.320.300.35
Inventory Turnover
3.212.972.713.133.413.00
Quick Ratio
0.590.490.541.581.181.05
Current Ratio
0.820.670.771.841.351.20
Return on Equity (ROE)
-39.64%-40.24%-65.84%7.21%7.19%5.62%
Return on Assets (ROA)
3.23%3.42%1.89%4.17%2.83%3.13%
Return on Invested Capital (ROIC)
7.97%7.47%3.95%7.10%5.44%6.22%
Return on Capital Employed (ROCE)
11.20%13.70%6.90%9.40%7.80%7.40%
Earnings Yield
-12.43%-12.43%-32.88%3.77%3.61%2.30%
FCF Yield
7.51%9.16%7.15%5.21%3.50%-10.69%
Dividend Yield
---0.50%0.50%0.38%
Payout Ratio
---45.81%49.44%54.73%
Buyback Yield / Dilution
-0.14%0.01%-0.01%-0.04%0.33%-0.23%
Total Shareholder Return
-0.14%0.01%-0.01%0.46%0.83%0.15%
Source: S&P Global Market Intelligence. Standard template. Financial Sources.